SS Innovations International (SSII) Cash & Current Investments (2016 - 2026)
SS Innovations International (SSII) posted Cash & Current Investments of $23.6 million for Q1 2026, up 158.21% sequentially from $9.1 million in Q4 2025, and up 8.51% YoY from $21.8 million in Q1 2025.
SS Innovations International (SSII) Cash & Current Investments (2016 - 2026) Analysis & Trends
SS Innovations International has reported Cash & Current Investments for 11 years, with the latest figure at $23.6 million in Q1 2026.
- Quarterly Cash & Current Investments rose 8.51% year-over-year to $23.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $23.6 million (up 8.51% YoY) and the FY2025 annual result came in at $9.1 million, up 45.03% from the prior year.
- Cash & Current Investments grew to $23.6 million in Q1 2026 per SSII's latest filing, from $9.1 million in the prior quarter.
- Over five years, Cash & Current Investments peaked at $23.6 million in Q1 2026 and troughed at $261089.0 in Q2 2022.
- A 5-year average of $7.3 million and a median of $6.3 million in 2024 frame the typical range for Cash & Current Investments.
- The sharpest annual moves came in 2023 and 2024: Cash & Current Investments surged 2467.84% in 2023, then slumped 50.2% in 2024.
- Over 5 years, Cash & Current Investments stood at $274625.0 in 2022, then soared by 2467.84% to $7.1 million in 2023, then retreated by 10.59% to $6.3 million in 2024, then surged by 45.03% to $9.1 million in 2025, then surged by 158.21% to $23.6 million in 2026.
- According to Business Quant data, Cash & Current Investments over the past three periods registered $23.6 million, $9.1 million, and $11.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 3.48 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 4.25 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 1.95 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 3.32 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 482.30 Mn |
| 10 | SS Innovations International | 731.50 Mn | 709.20 Mn | 7.10 Mn | 22.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 22.30 Mn |
| Mar 31, 2026 | 23.61 Mn |
| Dec 31, 2025 | 9.14 Mn |
| Sep 30, 2025 | 11.71 Mn |
| Jun 30, 2025 | 17.26 Mn |
| Mar 31, 2025 | 21.76 Mn |
| Dec 31, 2024 | 6.31 Mn |
| Sep 30, 2024 | 5.78 Mn |
| Jun 30, 2024 | 813,453.00 |
| Mar 31, 2024 | 6.57 Mn |
| Dec 31, 2023 | 7.05 Mn |
| Sep 30, 2023 | 11.61 Mn |
| Jun 30, 2023 | 466,346.00 |
| Mar 31, 2023 | 448,543.00 |
| Dec 31, 2022 | 274,625.00 |
| Sep 30, 2022 | 514,143.00 |
| Jun 30, 2022 | 261,089.00 |
| Mar 31, 2022 | 346,869.00 |
| Dec 31, 2021 | 405,774.00 |
| Sep 30, 2021 | 205,195.00 |